Alcohol detox for Boynton Beach — CIWA-Ar-guided, medically supervised, discretion assured.

RECO Island is a small-census, physician-led detox and residential facility twelve minutes south of Boynton Beach in Delray. Alcohol withdrawal is managed with CIWA-Ar scoring, symptom-triggered benzodiazepine dosing, and 24/7 nursing under physician oversight — then transitioned directly into in-house residential care without a third-party handoff or waitlist. For families in Renaissance Commons, Quantum Park, or Ocean Ridge, the short drive keeps visitation, family therapy, and aftercare planning logistically simple.

Boynton Beach sits seven miles north of RECO Island’s Delray Beach campus along Federal Highway, close enough that residents of Renaissance Commons, Quantum Park, or Ocean Ridge reach the front door in about twelve minutes. For someone weighing whether alcohol withdrawal warrants medical supervision, that drive time matters: it is shorter than the trip to most Boynton supermarkets, which means a physician-led detox is logistically no farther away than a routine errand.

Alcohol withdrawal is the one that can kill you

Alcohol withdrawal is clinically distinct from opioid, stimulant, or cannabis withdrawal in one specific respect: it carries genuine mortality. Withdrawal seizures, delirium tremens, and cardiovascular complications drive a small but real death rate in unsupervised withdrawal — historically cited between 1% and 5% for untreated DTs, higher in older or medically compromised patients. This is why the ASAM Criteria and every major clinical guideline treat alcohol detox as a medical procedure rather than a comfort measure.

Risk stratification at intake follows the evidence. Prior withdrawal seizures or DTs are the strongest single predictor of a complicated course, followed by high daily consumption, longer duration of use, older age, medical comorbidities such as cirrhosis or cardiovascular disease, and concurrent benzodiazepine, sedative, or opioid use. The Prediction of Alcohol Withdrawal Severity Scale (PAWSS) is applied at admission alongside the ASAM Criteria dimensions to assign the appropriate level of care.

High-risk clients — anyone with a documented seizure history, DTs history, or a PAWSS score above the treatment threshold — are staffed for more frequent nursing assessment and closer physician oversight. The point of a physician-led detox is not to make withdrawal comfortable; it is to prevent death, seizures, aspiration, and permanent neurologic injury. Comfort is a downstream benefit of doing the medical work correctly.

CIWA-Ar and symptom-triggered benzodiazepine dosing

The Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar) is the standard bedside instrument for scoring alcohol withdrawal severity. It measures ten domains, reassessed every one to four hours depending on severity and trajectory:

• nausea and vomiting, tremor, paroxysmal sweats
• anxiety, agitation, headache
• tactile, auditory, and visual disturbances
• orientation and clouding of sensorium

Scores below 8–10 usually do not require pharmacologic treatment; scores of 15 or higher indicate significant withdrawal and warrant medication. RECO Island’s alcohol detox program uses symptom-triggered benzodiazepine dosing rather than fixed-schedule tapers by default. The evidence is unambiguous: symptom-triggered protocols produce shorter treatment duration, lower cumulative benzodiazepine exposure, and equivalent or better safety endpoints compared with fixed-dose regimens.

Chlordiazepoxide is preferred when hepatic function is intact; lorazepam is chosen when there is significant liver disease or in older adults because it lacks active metabolites; diazepam may be used for loading in severe presentations. Adjunctive gabapentin is often added for mild-to-moderate withdrawal and for sleep in the sub-acute phase. Clonidine or a beta-blocker may be used for adrenergic symptoms but never as a substitute for benzodiazepine coverage — they mask CIWA scores without preventing seizures.

Thiamine, folate, and Wernicke prevention

Chronic alcohol use produces thiamine deficiency through poor intake, malabsorption, and impaired hepatic storage. Untreated deficiency causes Wernicke’s encephalopathy — the classical triad of ophthalmoplegia, ataxia, and confusion, though the full triad appears in fewer than one in five confirmed cases. The neurologic lesion, once established, may progress to Korsakoff syndrome and permanent memory impairment. The cost of missing thiamine replacement is not a delayed recovery; it is neurologic damage that does not reverse.

RECO Island’s admission orders include parenteral thiamine — 100 mg intramuscularly or intravenously on day one, continued daily through the acute phase — administered before any glucose-containing fluids, because glucose loading in a thiamine-deficient patient can precipitate Wernicke’s. Folate 1 mg daily, a multivitamin, and magnesium replacement are standard; magnesium supports both seizure prophylaxis and correction of the hypomagnesemia common in heavy drinkers.

Medical workup at intake also screens for the comorbidities that accompany alcohol use disorder: liver function (AST, ALT, GGT, INR), a complete blood count for macrocytic anemia and thrombocytopenia, a comprehensive metabolic panel, lipase if pancreatitis is suspected, and an EKG. These labs are not academic — they change how the detox is medicated and monitored.

MAT initiation during detox and the transition to residential

For clients moving from detox into RECO Island’s in-house residential program, medication-assisted treatment for alcohol use disorder is discussed during the detox stay and, where appropriate, initiated before discharge so the medication is established on transition. Three FDA-approved options are available: oral naltrexone at 50 mg daily or long-acting injectable naltrexone (Vivitrol) at 380 mg intramuscular monthly; acamprosate at 666 mg three times daily; and disulfiram at 250 mg daily for selected patients with reliable external adherence structures and no cardiac contraindications.

Naltrexone requires a seven-to-ten-day opioid-free window before administration to avoid precipitated withdrawal — a window that a supervised detox conveniently provides. It is first-line pharmacotherapy for most patients with alcohol use disorder and has the strongest evidence base for reduction in heavy drinking days. Acamprosate is initiated once abstinence is stabilized, typically in the final days of detox or the first days of residential, and is preferred when hepatic disease contraindicates naltrexone.

The MAT decision is written into the treatment plan alongside psychiatric medication review — sertraline or another SSRI for co-occurring depression, buspirone or an SNRI for anxiety, quetiapine or aripiprazole where mood or psychotic symptoms warrant, lithium for the bipolar spectrum — and a psychotherapy plan built around CBT for relapse prevention, motivational interviewing for ambivalence, and EMDR or trauma-focused CBT where trauma is a driver. Detox that ends without a treatment plan is the setup for relapse.

What to expect on the first day

Admissions from Boynton Beach typically follow a phone call to the admissions team, an insurance verification usually completed the same day, and a scheduled arrival time at the Delray Beach campus. Intake runs two to three hours: history and physical performed by the admitting physician or advanced practice provider, laboratory draw, EKG, PAWSS and CIWA-Ar baseline, medication reconciliation, and a psychiatric screening using standardized instruments (PHQ-9 for depression, GAD-7 for anxiety, and a full substance use history).

Clients are shown to their room, personal belongings are inventoried, and the first dose of thiamine and — if the CIWA-Ar score warrants it — benzodiazepine is administered. Nursing performs vital signs and CIWA-Ar reassessment on a defined schedule through the first 72 hours, which is the highest-risk window for seizures and DTs. Family contact is established with signed HIPAA releases, and the initial treatment planning session is scheduled within the first 48 hours.

Insurance and getting to RECO Island from Boynton Beach

RECO Island is in-network or accepts out-of-network benefits for the major carriers most Boynton Beach residents carry: Florida Blue, Blue Cross Blue Shield, Aetna, Cigna, UnitedHealthcare, and Humana. Verification of benefits — deductible remaining, coinsurance, prior authorization requirements, and expected out-of-pocket — is completed before admission. Single-case agreements and structured self-pay arrangements are also available.

From Boynton Beach the drive south to Delray is straightforward: I-95 or Federal Highway, roughly twelve minutes without traffic from Renaissance Commons or Quantum Park, slightly longer from Hunters Run or Briny Breezes. The short drive is often the deciding factor for family involvement — visits, family therapy sessions, and the transition back to home routines remain geographically manageable in a way that an out-of-state facility never is.

Serving residents of: Renaissance Commons, Ocean Ridge, Quantum Park, Hunters Run, Briny Breezes.